Gastroenterology · Teaneck, NJ
NPI
1710951348
Since 2006
Specialty
Gastroenterology
Code 174400000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1086 Teaneck Rd, Suite 4c
Teaneck, NJ, 07666
Phone (201) 837-9449
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
906 services
Medicare patients, 2024
514
Average age 75
Drug cost, 2024
$672K
1,240 prescriptions
Company payments, 2025
$524
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael H Schmidt was code 99214 (office e&m - established), 146 times for 125 patients. In total Michael H Schmidt billed 906 services in 33 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-07-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 146 | 125 | $104.45 | $15K |
| 43239 Upper GI Endoscopy | Facility | 112 | 106 | $97.40 | $11K |
| 45378 Lower GI Endoscopy - Other | Facility | 66 | 66 | $152.31 | $10K |
| 99213 Office E&M - Established | Office | 57 | 54 | $77.09 | $4,394 |
| 45380 Lower GI Endoscopy - Other | Facility | 56 | 55 | $154.54 | $8,654 |
| 99231 Hospital E&M - Subsequent | Facility | 55 | 41 | $42.44 | $2,334 |
| 99204 Office E&M - New | Office | 48 | 48 | $131.02 | $6,289 |
| 99203 Office E&M - New | Office | 46 | 46 | $85.88 | $3,950 |
| 45385 Colonoscopy - Lesion Removal | Facility | 43 | 42 | $212.84 | $9,152 |
| 99232 Hospital E&M - Subsequent | Facility | 42 | 23 | $68.92 | $2,895 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 37 | 37 | $201.61 | $7,460 |
| 76981 Ultrasound - Nonspecific | Office | 29 | 29 | $88.38 | $2,563 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 25 | 25 | $201.35 | $5,034 |
| 99223 Hospital E&M - Initial | Facility | 24 | 23 | $150.07 | $3,602 |
| 99221 Hospital E&M - Initial | Facility | 20 | 20 | $72.38 | $1,448 |
By year: 2022 $101K for 856 services; 2023 $111K for 950 services; 2024 $106K for 906 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82270 Immunoassay | 11 | 11 | $4.29 | $47.19 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael H Schmidt prescribed most often to Medicare patients was Omeprazole, with 295 prescriptions and refills. In total Michael H Schmidt wrote 1,240 Medicare prescriptions that cost $672K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 295 | 795 | 98 | $4,722 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 272 | 272 | 264 | $16K |
| Pantoprazole Sodium Generic | 168 | 486 | 60 | $2,999 |
| Esomeprazole Magnesium Generic | 85 | 220 | 24 | $4,064 |
| Famotidine Generic | 59 | 162 | 22 | $1,212 |
| Lansoprazole Generic | 27 | 79 | Under 11 | $739 |
| Creon Lipase/Protease/Amylase | 25 | 29 | Under 11 | $56K |
| Mesalamine Generic | 24 | 64 | Under 11 | $16K |
| Cholestyramine Light Cholestyramine | 22 | 47 | 12 | $4,109 |
| Ursodiol Generic | 21 | 35 | Under 11 | $2,842 |
| Dexlansoprazole Dr Dexlansoprazole | 16 | 44 | Under 11 | $6,949 |
| Tenofovir Disoproxil Fumarate Generic | 15 | 25 | Under 11 | $2,942 |
| Cholestyramine Cholestyramine (With Sugar) | 14 | 20 | Under 11 | $1,608 |
| Stelara Ustekinumab | 13 | 29 | Under 11 | $463K |
| Ondansetron Odt Ondansetron | 13 | 13 | Under 11 | $211 |
Brand drugs: - claims; generic drugs: 1,047 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael H Schmidt $524 ($524 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $191.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 17 | $191 |
| Madrigal Pharmaceuticals MDGL | 5 | $86.61 |
| Pfizer Inc. PFE | 4 | $68.98 |
| Aimmune Therapeutics, Inc. | 2 | $37.3 |
| Celltrion USA Inc. 068270.KS | 2 | $36.11 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $20.4 |
| Intercept Pharmaceuticals, Inc. | 1 | $20.34 |
| Janssen Biotech, Inc. JNJ | 1 | $18.87 |
| Ardelyx, Inc. ARDX | 1 | $18.73 |
| Lilly USA, LLC LLY | 1 | $18.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.